Combination therapy induced a substantial increase in infiltration of CD3+ T cells into the primary breast tumors that was produced by either PD-1 blockade or vaccine alone as compared to control (Fig. 3C-D). The gene discussed is PDCD1; the disease is breast neoplasm.